A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis

NCT02287922 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

251

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: ALX-0061
BIOLOGICAL: Placebo
BIOLOGICAL: Tocilizumab

Sponsor

Ablynx, a Sanofi company